Estrogen receptor [aapp, rcpt]
Modulation [spco]
reduction [npop]
Risk [qlco]
Breast [bpoc]
Cancer [neop]
Osteoporosis [dsyn]
coronary heart disease [dsyn]
Recognition [menp]
Estrogen receptor [aapp, rcpt]
Modulation [spco]
Laboratory [mnob, orgt]
Result [ftcn]
development [phsf]
Two [qnco]
Selective Estrogen Receptor Modulators [horm, phsu]
Tamoxifen [orch, phsu]
Raloxifene [orch, phsu]
Clinical [qlco]
Application [hlca]
Health [idcn]
Women [popg]
Selective Estrogen Receptor Modulators [horm, phsu]
Antiestrogenic [phsu]
Breast [bpoc]
Estrogen [horm, phsu, strd]
Bones [bpoc]
Circulating [ftcn]
cholesterol levels [lbpr]
Selective Estrogen Receptor Modulators [horm, phsu]
Different [qlco]
degrees [qnco]
Estrogenic [horm, orch, phsu]
Uterus [bpoc]
Tamoxifen [orch, phsu]
Incidence [qnco]
Breast Cancer [neop]
premenopausal [tmco]
postmenopausal [tmco]
Women [popg]
At risk [qlco]
Disease [dsyn]
Contrast [qlco]
Raloxifene [orch, phsu]
Risk [qlco]
Osteoporosis [dsyn]
postmenopausal [tmco]
Women [popg]
High Risk [qlco]
Osteoporosis [dsyn]
study trial [resa]
Tamoxifen [orch, phsu]
Raloxifene [orch, phsu]
Currently [tmco]
Compare [acty]
Ability [orga]
Selective Estrogen Receptor Modulators [horm, phsu]
Breast Cancer [neop]
Incidence [qnco]
High Risk [qlco]
postmenopausal [tmco]
Women [popg]
Intense [qlco]
Interest [menp]
Understanding [menp]
Molecular [qlco]
Mechanism [ftcn]
Action [ftcn]
Selective Estrogen Receptor Modulators [horm, phsu]
Target [ftcn]
Sites [spco]
Woman [popg]
body [humn]
Understanding [menp]
Targeted [ftcn]
actions [ftcn]
Novel [tmco]
Drug [phsu]
Group [idcn]
Result [ftcn]
Introduction [hlca]
New [tmco]
Medicines [phsu]
applications [hlca]
preventive [ftcn]
Agent [chvf]
Treatments [topp]
Breast Cancer [neop]
Endometrial Cancer [neop]
coronary heart disease [dsyn]
Osteoporosis [dsyn]
